Future of e-Cigarettes in Brazil: Anvisa's Public Meeting

Nov.24.2023

Brazil's health regulator, Anvisa, will hold a public meeting on December 1 to discuss the future development of e-cigarettes.

According to Brazilian media outlet Odia, the National Health Surveillance Agency of Brazil (Anvisa) is set to hold a public meeting next Friday (December 1st) to discuss the future development of e-cigarettes in the country.

The e-cigarette has been banned in Brazil since 2009 due to a decree issued by Anvisa. However, currently, the regulatory agency's decision is under review.

In Brazil, despite a ban, the usage of e-cigarettes has continued to grow, with the number of consumers steadily increasing. According to a survey conducted by Ipec in 2022, there are approximately 2.2 million regular users of e-cigarettes in Brazil, all of whom are operating within an illegal market where the source of raw materials and associated risks cannot be determined.

The President of the Information Council for Reducing Smoking Hazards (Direta), Alexandro Lucian, has emphasized the importance of regulations in ensuring consumer safety.

A study, commissioned by the UK government and published in 2022 by King's College London, has reviewed over 400 scientific papers, revealing that e-cigarettes are 95% less harmful than traditional cigarettes. It is worth noting that research on e-cigarettes is prohibited in Brazil.

On the day of the Anvisa meeting, a consumer protest was planned with the aim of exerting pressure on authorities for adequate and safe regulation of e-cigarettes.

According to Lucian, the presence of consumers in this democratic dialogue environment is of utmost significance.

References:

[1] Anvisa marca reunião pública para discutir se cigarro eletrônico deve ser regulamentado Brasil

#Brazil #E-cigarette #E-cigarettes and Tobacco

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market

As global competition in the nicotine pouch market accelerates, Korea’s tobacco major KT&G has moved with a “Partnership + Acquisition” strategy, teaming up with Altria to acquire Nordic pouch maker Another Snus Factory (brand “LOOP”). Why deploy capital now, and why take this route? Drawing on company disclosures, regulatory monitoring and on-site observations from InterTabac Dortmund, 2Firsts analyzes KT&G’s strategic calculus and the signals behind this move.

Nov.05

5th Circuit Reviews FDA’s Compliance on Small-Business Impact of Vape Rule

A Fifth Circuit panel expressed doubts about whether the U.S. Food and Drug Administration complied with the Regulatory Flexibility Act when issuing its 2021 final rule on premarket tobacco product applications. Vape companies argued the FDA relied on outdated and inaccurate economic data, while the government said the challenged requirements stem from the Tobacco Control Act.

Dec.03 by 2FIRSTS.ai

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade

The Fourth Meeting of the Parties (MOP4) to the Protocol to Eliminate Illicit Trade in Tobacco Products opened in Geneva on November 24, 2025. With 60 Parties participating, the meeting focuses on strengthening legal action and international cooperation to combat illicit trade, which accounts for about 11% of the global tobacco market and costs governments billions in lost tax revenue.